Showing 1 - 10 of 72
Persistent link: https://www.econbiz.de/10009522810
Persistent link: https://www.econbiz.de/10003459136
Persistent link: https://www.econbiz.de/10003846596
Persistent link: https://www.econbiz.de/10003577226
Persistent link: https://www.econbiz.de/10003844268
In April 2003 a new payment system for hospitals called Payment by Results (PbR) was introduced in England. The new system is a fixed tariff case-mix based prospective payment system which reimburses hospitals for the type and amount of care they provide. By linking provider income more closely...
Persistent link: https://www.econbiz.de/10014049862
This report is a critique of the Centre for Health Economics Research Paper No. 81 (CHERP81), which estimates that the marginal cost of a QALY for the NHS in England in 2008/9 was £12,936. There is much to admire in the approach, detailed analysis, and reporting set out in CHERP81 and we...
Persistent link: https://www.econbiz.de/10014134103
Expenditure on medicines is a readily identifiable element of health service costs. As such, it is the focus of much attention by payers, not least in the UK despite the fact that the ex-manufacturer cost of medicines represents less than 10% of total UK National Health Service (NHS)...
Persistent link: https://www.econbiz.de/10013019275
Objectives: The purpose of this research is to identify the attributes to include in an orphan medicinal product (OMP) value framework, determine their relative importance via a multi-criteria decision analysis (MCDA) process, and test whether an MCDA approach can practically support decision...
Persistent link: https://www.econbiz.de/10013019295
Objectives: The objectives of this research were to identify the cost-effectiveness of health care services at the margin in the Scottish NHS; consider the extent to which the thresholds observed in Scottish NHS decision making are consistent with the threshold being used to make judgements...
Persistent link: https://www.econbiz.de/10013019353